We will be closed in honor of Memorial Day on Monday, May 27. We will return to regular hours on Tuesday, May 28. Thank you for your understanding!

General Info

  1. March 26, 2024

    Kasra Moaddel Joins Revelation Pharma

    FOR IMMEDIATE RELEASE

    Kasra Moaddel Joins Revelation Pharma as Vice President of Corporate Development

    Tampa, FL - Revelation Pharma proudly welcomes Kasra Moaddel as the newest addition to its leadership team, assuming the role of Vice President of Corporate Development. With a stellar background in mergers & acquisitions (M&A) and corporate development, Moaddel brings a wealth of experience and strategic insight to drive Revelation Pharma's growth and expansion initiatives.

    Throughout his distinguished career, Moaddel has made significant contributions to esteemed healthcare entities, leaving a lasting impact on the industry. Particularly noteworthy is his instrumental role in shaping the corporate development and strategy of a prominent healthcare organization in Southern California. His strategic foresight and leadership played a pivotal role in establishing the organization as a key player in the region's healthcare scene.

    Read More
  2. February 27, 2024

    A Guide to Writing a Compounded Prescription for Hormone Replacement Therapy (HRT)

    Zoom-header2

    Hormone Replacement Therapy (HRT) is a treatment option widely prescribed for patients experiencing various symptoms related to hormonal imbalances. Compounded prescriptions for HRT allow healthcare practitioners to tailor medications specific to individual patient’s needs, providing a more personalized approach to therapy. This blog will guide practitioners through writing a compounded prescription for Hormone Replacement Therapy to ensure optimal patient care and treatment outcomes.

    1. Patient Assessment

    Before writing a compounded prescription for HRT, it is critical to conduct

    Read More
  3. January 30, 2024

    Ketamine ain’t esketamine

    Ketamine’s been in the news a lot as a potential treatment for depression, PTSD, and more. It’s not FDA-approved (yet), but its cousin esketamine is approved for treating some forms of depression.

    That gets confusing, especially among lay people who don’t realize how important those extra two letters are. (Consider how you’d feel if you landed in Kansas instead of Arkansas, especially during tornado season.)

    Luckily, the good folks at Medscape have a great overview of the differences between ketamine and esketamine, including how they’re delivered, what they’re approved for, and the issues popping up as clinics offer “treatment” that could be ineffective, dangerous, or somewhere in between.

    While ketamine and esketamine are chemically related, they are very distinct in terms of their chemical compositions, the FDA-approved indications, dosing, and administration, as well as the level of study and data

    Read More
  4. January 09, 2024

    Compounded Liothyronine (T3): What you need to know

    Clinical info on liothyronine

    By Zoom Heaton, RPh., CDCES, ABAAHP, FAAMFM
    Clinical Liaison – Women’s Health
    Revelation Pharma

    Liothyronine is a synthetic form of triiodothyronine (T3), one of the two primary thyroid hormones produced by the thyroid gland. It is commonly used in the treatment of hypothyroidism, a condition characterized by insufficient production of thyroid hormones.

    Clinical studies have demonstrated the effectiveness of liothyronine in improving symptoms and normalizing thyroid hormone levels in patients with hypothyroidism. One study, published in The Journal of Clinical Endocrinology & Metabolism, investigated the effects of liothyronine and levothyroxine (T4) combination therapy versus levothyroxine monotherapy in patients with hypothyroidism. The study found that combination therapy resulted in greater improvements

    Read More
Page